YAP1 and hepatocellular carcinoma: Indeed, verteporfin (inhibits YAP1/TEAD interaction) plus aav‐shHMGCS1 as a combination treatment strategy for CSN6‐high HCC PDX demonstrated a better treatment efficacy than verteporfin or aav‐shHMGCS1 alone.